Discover the imaginary worlds of Victor Hugo, one of France’s most famous writers, at this exhibition of his rarely-seen works on paper. Victor Hugo (1802–1885) was a leading public figure in ...

LONDON - Angle PLC (AIM: AGL; OTCQX: ANPCY), a leading company in the field of liquid biopsy, has announced the grant of Long-Term Incentive Plan (LTIP) options and share options to its executive ...

NCIS: Origins returns from a brief hiatus with a new episode on Monday, March 24, and we’re finally going to learn more about Mary Jo (Tyla Abercrumbie)! In “To Have and to Hold,” the team ...

UPDATE ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei ...

The non-executive directors of the Company do not hold share options. As at 20 March 2025, the Company has 322,641,668 Ordinary Shares in issue. The below notification made in accordance with the ...

Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...

Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...

LONDON - Angle PLC (AIM: AGL; OTCQX: ANPCY), a leading company in the field of liquid biopsy, has announced the grant of Long-Term Incentive Plan (LTIP) options and share options to its executive ...

GUILDFORD, SURREY / ACCESS Newswire / March 21, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, under the Remuneration Policy approved by the ...

4,800,000 12,000,000 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Andrew Newland 2 Reason for the notification a) Position/status Chief ...